Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial.

Smith TT, Koopmeiners JS, White CM, Denlinger-Apte RL, Pacek LR, De Jesús VR, Wang L, Watson C, Blount BC, Hatsukami DK, Benowitz NL, Donny EC, Carpenter MJ.

Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):880-886. doi: 10.1158/1055-9965.EPI-19-0963. Epub 2020 Feb 26.

PMID:
32102910
2.

Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes.

Smith TT, Koopmeiners JS, Hatsukami DK, Tessier KM, Benowitz NL, Murphy SE, Strasser AA, Tidey JW, Blount BC, Valentin L, Bravo Cardenas R, Watson C, Pirkle JL, Donny EC.

Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):643-649. doi: 10.1158/1055-9965.EPI-19-0905. Epub 2020 Feb 26.

PMID:
32102909
3.

Forced treadmill running reduces systemic inflammation yet worsens upper limb discomfort in a rat model of work-related musculoskeletal disorders.

Smith TTG, Barr-Gillespie AE, Klyne DM, Harris MY, Amin M, Paul RW, Cruz GE, Zhao H, Gallagher S, Barbe MF.

BMC Musculoskelet Disord. 2020 Jan 30;21(1):57. doi: 10.1186/s12891-020-3085-z.

4.

The Role of Compensation in Nicotine Reduction.

Benowitz NL, Donny EC, Edwards KC, Hatsukami D, Smith TT.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S16-S18. doi: 10.1093/ntr/ntz120.

5.

The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings.

Smith TT, Donny EC, Luo X, Allen AM, Carroll DM, Denlinger-Apte RL, Dermody SS, Koopmeiners JS, McClernon FJ, Pacek LR, Vandrey R, Hatsukami DK.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S73-S80. doi: 10.1093/ntr/ntz158.

6.

Behavioral Outcomes of Nicotine Reduction in Current Adult Smokers.

Smith TT, Heckman BW, Tidey JW, Colby SM, Cummings KM.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S125-S127. doi: 10.1093/ntr/ntz102. No abstract available.

7.

Anticipated Effects of Nicotine Reduction on Youth Smoking Initiation and Maintenance.

Colby SM, Cassidy RN, Denlinger-Apte R, Smith TT, Pacek LR, McClernon FJ, Tidey JW.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S46-S48. doi: 10.1093/ntr/ntz101.

8.

Effects of Very Low Nicotine Content Cigarettes on Smoking Behavior and Biomarkers of Exposure in Menthol and Non-menthol Smokers.

Denlinger-Apte RL, Kotlyar M, Koopmeiners JS, Tidey JW, Luo X, Benowitz NL, Jensen JA, Ikuemonisan JO, Pacek LR, Smith TT, Vandrey R, Donny EC, Hatsukami DK.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S63-S72. doi: 10.1093/ntr/ntz160.

9.

Very low nicotine content cigarettes disrupt the feedback loop of affective states and smoking behavior.

Robinson JD, Kypriotakis G, al'Absi M, Denlinger-Apte RL, Drobes DJ, Leischow S, McClernon FJ, Pacek LR, Severson H, Smith TT, Donny EC, Luo X, Jensen JA, Strayer LG, Cinciripini PM, Hatsukami DK.

Nicotine Tob Res. 2019 Nov 8. pii: ntz209. doi: 10.1093/ntr/ntz209. [Epub ahead of print]

PMID:
31701153
10.

Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine.

Smith TT, Koopmeiners JS, Tessier KM, Davis EM, Conklin CA, Denlinger-Apte RL, Lane T, Murphy SE, Tidey JW, Hatsukami DK, Donny EC.

Am J Prev Med. 2019 Oct;57(4):515-524. doi: 10.1016/j.amepre.2019.05.010.

PMID:
31542129
11.

The impact of e-liquid propylene glycol and vegetable glycerin ratio on ratings of subjective effects, reinforcement value, and use in current smokers.

Smith TT, Heckman BW, Wahlquist AE, Cummings KM, Carpenter MJ.

Nicotine Tob Res. 2019 Aug 10. pii: ntz130. doi: 10.1093/ntr/ntz130. [Epub ahead of print]

PMID:
31403695
12.

The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects.

Fadus MC, Smith TT, Squeglia LM.

Drug Alcohol Depend. 2019 Aug 1;201:85-93. doi: 10.1016/j.drugalcdep.2019.04.011. Epub 2019 May 23. Review.

PMID:
31200279
13.

Evaluation of rapid polymerase chain reaction-based organism identification of gram-positive cocci for patients with a single positive blood culture.

MacVane SH, Raux BR, Smith TT.

Eur J Clin Microbiol Infect Dis. 2019 Aug;38(8):1471-1479. doi: 10.1007/s10096-019-03574-3. Epub 2019 May 11.

PMID:
31079314
14.

Racial Discrimination, Disease Activity, and Organ Damage: The Black Women's Experiences Living With Lupus (BeWELL) Study.

Chae DH, Martz CD, Fuller-Rowell TE, Spears EC, Smith TTG, Hunter EA, Drenkard C, Lim SS.

Am J Epidemiol. 2019 Aug 1;188(8):1434-1443. doi: 10.1093/aje/kwz105.

PMID:
31062841
15.

Impact of E-cigarette Sampling on Cigarette Dependence and Reinforcement Value.

Smith TT, Wahlquist AE, Heckman BW, Cummings KM, Carpenter MJ.

Nicotine Tob Res. 2020 Feb 6;22(2):297-301. doi: 10.1093/ntr/nty258.

PMID:
30500925
16.

Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes.

Denlinger-Apte RL, Tidey JW, Koopmeiners JS, Hatsukami DK, Smith TT, Pacek LR, McClernon FJ, Donny EC.

Tob Control. 2019 May;28(3):352-355. doi: 10.1136/tobaccocontrol-2018-054622. Epub 2018 Nov 1.

PMID:
30385649
17.

Nanoparticles That Reshape the Tumor Milieu Create a Therapeutic Window for Effective T-cell Therapy in Solid Malignancies.

Zhang F, Stephan SB, Ene CI, Smith TT, Holland EC, Stephan MT.

Cancer Res. 2018 Jul 1;78(13):3718-3730. doi: 10.1158/0008-5472.CAN-18-0306. Epub 2018 May 14.

18.

Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health.

Smith TT, Hatsukami DK, Benowitz NL, Colby SM, McClernon FJ, Strasser AA, Tidey JW, White CM, Donny EC.

Prev Med. 2018 Dec;117:8-14. doi: 10.1016/j.ypmed.2018.03.021. Epub 2018 Mar 29.

19.

Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.

Dermody SS, McClernon FJ, Benowitz N, Luo X, Tidey JW, Smith TT, Vandrey R, Hatsukami D, Donny EC.

Exp Clin Psychopharmacol. 2018 Jun;26(3):223-232. doi: 10.1037/pha0000179. Epub 2018 Mar 5.

20.

Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.

Smith TT, Tamma PD, Do TB, Dzintars KE, Zhao Y, Cosgrove SE, Avdic E.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):161-163. doi: 10.1016/j.diagmicrobio.2018.01.027. Epub 2018 Feb 3.

PMID:
29496381
21.

Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae.

Santevecchi BA, Smith TT, MacVane SH.

Int J Antimicrob Agents. 2018 Apr;51(4):629-635. doi: 10.1016/j.ijantimicag.2018.01.016. Epub 2018 Feb 2.

PMID:
29408227
22.

Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks.

Pacek LR, Joseph McClernon F, Denlinger-Apte RL, Mercincavage M, Strasser AA, Dermody SS, Vandrey R, Smith TT, Nardone N, Hatsukami DK, Koopmeiners JS, Kozink RV, Donny EC.

Tob Control. 2018 Jul;27(4):420-426. doi: 10.1136/tobaccocontrol-2017-053689. Epub 2017 Jul 22.

23.

Behavioral Economic Laboratory Research in Tobacco Regulatory Science.

Tidey JW, Cassidy RN, Miller ME, Smith TT.

Tob Regul Sci. 2016 Oct;2(4):440-451. doi: 10.18001/TRS.2.4.13.

24.

Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors.

Smith TT, Moffett HF, Stephan SB, Opel CF, Dumigan AG, Jiang X, Pillarisetty VG, Pillai SPS, Wittrup KD, Stephan MT.

J Clin Invest. 2017 Jun 1;127(6):2176-2191. doi: 10.1172/JCI87624. Epub 2017 Apr 24.

25.

Validation of a laboratory-developed test of human sperm capacitation.

Moody MA, Cardona C, Simpson AJ, Smith TT, Travis AJ, Ostermeier GC.

Mol Reprod Dev. 2017 May;84(5):408-422. doi: 10.1002/mrd.22801. Epub 2017 Apr 18.

26.

In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.

Smith TT, Stephan SB, Moffett HF, McKnight LE, Ji W, Reiman D, Bonagofski E, Wohlfahrt ME, Pillai SPS, Stephan MT.

Nat Nanotechnol. 2017 Aug;12(8):813-820. doi: 10.1038/nnano.2017.57. Epub 2017 Apr 17.

27.

Animal Research on Nicotine Reduction: Current Evidence and Research Gaps.

Smith TT, Rupprecht LE, Denlinger-Apte RL, Weeks JJ, Panas RS, Donny EC, Sved AF.

Nicotine Tob Res. 2017 Sep 1;19(9):1005-1015. doi: 10.1093/ntr/ntx077.

28.

Self-administered nicotine differentially impacts body weight gain in obesity-prone and obesity-resistant rats.

Rupprecht LE, Smith TT, Donny EC, Sved AF.

Physiol Behav. 2017 Jul 1;176:71-75. doi: 10.1016/j.physbeh.2017.02.007. Epub 2017 Feb 9.

29.

Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes.

Rupprecht LE, Koopmeiners JS, Dermody SS, Oliver JA, al'Absi M, Benowitz NL, Denlinger-Apte R, Drobes DJ, Hatsukami D, McClernon FJ, Pacek LR, Smith TT, Sved AF, Tidey J, Vandrey R, Donny EC.

Tob Control. 2017 Mar;26(e1):e43-e48. doi: 10.1136/tobaccocontrol-2016-053301. Epub 2016 Nov 17.

30.

Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Henningfield JE, Smith TT, Kleykamp BA, Fant RV, Donny EC.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3829-3848. Epub 2016 Oct 21. Review.

31.

Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi-site clinical trial.

Smith TT, Cassidy RN, Tidey JW, Luo X, Le CT, Hatsukami DK, Donny EC.

Addiction. 2017 Feb;112(2):349-359. doi: 10.1111/add.13636. Epub 2016 Nov 28.

32.

Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation.

Smith TT, Rupprecht LE, Sved AF, Donny EC.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3953-3964. Epub 2016 Sep 14.

33.

Self-Administered Nicotine Suppresses Body Weight Gain Independent of Food Intake in Male Rats.

Rupprecht LE, Smith TT, Donny EC, Sved AF.

Nicotine Tob Res. 2016 Sep;18(9):1869-1876. doi: 10.1093/ntr/ntw113. Epub 2016 May 18.

34.

Nicotine Enhances Footshock- and Lithium Chloride-Conditioned Place Avoidance in Male Rats.

Buffalari DM, Mollica JK, Smith TT, Schassburger RL, Rinaman L, Thiels E, Donny EC, Sved AF.

Nicotine Tob Res. 2016 Sep;18(9):1920-3. doi: 10.1093/ntr/ntw098. Epub 2016 May 13.

35.

Nicotine and Anatabine Exposure from Very Low Nicotine Content Cigarettes.

Denlinger RL, Smith TT, Murphy SE, Koopmeiners JS, Benowitz NL, Hatsukami DK, Pacek LR, Colino C, Cwalina SN, Donny EC.

Tob Regul Sci. 2016 Apr;2(2):186-203. doi: 10.18001/TRS.2.2.9.

36.

Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine.

Smith TT, Rupprecht LE, Cwalina SN, Onimus MJ, Murphy SE, Donny EC, Sved AF.

Neuropsychopharmacology. 2016 Aug;41(9):2335-43. doi: 10.1038/npp.2016.36. Epub 2016 Mar 9.

37.

Long-term Virologic Suppression Despite Presence of Resistance-associated Mutations Among Perinatally HIV-infected Youth.

Smith TT, Hsu AJ, Hutton N, Womble F, Agwu AL.

Pediatr Infect Dis J. 2015 Dec;34(12):1365-8. doi: 10.1097/INF.0000000000000895.

PMID:
26780022
38.

Adolescent Rats Self-Administer Less Nicotine Than Adults at Low Doses.

Schassburger RL, Pitzer EM, Smith TT, Rupprecht LE, Thiels E, Donny EC, Sved AF.

Nicotine Tob Res. 2016 Sep;18(9):1861-1868. doi: 10.1093/ntr/ntw006. Epub 2016 Jan 13.

39.

Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.

Crow JR, Davis SL, Chaykosky DM, Smith TT, Smith JM.

Pharmacotherapy. 2015 Nov;35(11):1016-25. doi: 10.1002/phar.1644. Epub 2015 Nov 2. Review.

PMID:
26598094
40.

Effects of MAO inhibition and a combination of minor alkaloids, β-carbolines, and acetaldehyde on nicotine self-administration in adult male rats.

Smith TT, Schaff MB, Rupprecht LE, Schassburger RL, Buffalari DM, Murphy SE, Sved AF, Donny EC.

Drug Alcohol Depend. 2015 Oct 1;155:243-52. doi: 10.1016/j.drugalcdep.2015.07.002. Epub 2015 Jul 13.

41.

Behavioral mechanisms underlying nicotine reinforcement.

Rupprecht LE, Smith TT, Schassburger RL, Buffalari DM, Sved AF, Donny EC.

Curr Top Behav Neurosci. 2015;24:19-53. doi: 10.1007/978-3-319-13482-6_2. Review.

42.

Nicotine reduction as an increase in the unit price of cigarettes: a behavioral economics approach.

Smith TT, Sved AF, Hatsukami DK, Donny EC.

Prev Med. 2014 Nov;68:23-8. doi: 10.1016/j.ypmed.2014.07.005. Epub 2014 Jul 13.

43.

Low-dose nicotine self-administration is reduced in adult male rats naïve to high doses of nicotine: implications for nicotine product standards.

Smith TT, Schassburger RL, Buffalari DM, Sved AF, Donny EC.

Exp Clin Psychopharmacol. 2014 Oct;22(5):453-459. doi: 10.1037/a0037396. Epub 2014 Jul 7.

44.

Nicotine enhances the expression of a sucrose or cocaine conditioned place preference in adult male rats.

Buffalari DM, Marfo NY, Smith TT, Levin ME, Weaver MT, Thiels E, Sved AF, Donny EC.

Pharmacol Biochem Behav. 2014 Sep;124:320-5. doi: 10.1016/j.pbb.2014.06.013. Epub 2014 Jun 24.

45.

Concurrent performance as bouts of behavior.

Smith TT, McLean AP, Shull RL, Hughes CE, Pitts RC.

J Exp Anal Behav. 2014 Jul;102(1):102-25. doi: 10.1002/jeab.90. Epub 2014 May 26.

PMID:
24861997
46.

Oncolytic viral therapy: targeting cancer stem cells.

Smith TT, Roth JC, Friedman GK, Gillespie GY.

Oncolytic Virother. 2014 Feb;2014(3):21-33.

47.

Heat waves and health outcomes in Alabama (USA): the importance of heat wave definition.

Kent ST, McClure LA, Zaitchik BF, Smith TT, Gohlke JM.

Environ Health Perspect. 2014 Feb;122(2):151-8. doi: 10.1289/ehp.1307262. Epub 2013 Nov 22.

48.

Heat waves in the United States: definitions, patterns and trends.

Smith TT, Zaitchik BF, Gohlke JM.

Clim Change. 2013 Jun;118(3-4):811-825.

49.

Gradual and immediate nicotine reduction result in similar low-dose nicotine self-administration.

Smith TT, Levin ME, Schassburger RL, Buffalari DM, Sved AF, Donny EC.

Nicotine Tob Res. 2013 Nov;15(11):1918-25. doi: 10.1093/ntr/ntt082. Epub 2013 Jul 1.

50.

In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonists.

Bakker RA, Nicholas MW, Smith TT, Burstein ES, Hacksell U, Timmerman H, Leurs R, Brann MR, Weiner DM.

J Pharmacol Exp Ther. 2007 Jul;322(1):172-9. Epub 2007 Apr 2.

PMID:
17403993

Supplemental Content

Loading ...
Support Center